Latest stories on BDSX
Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026
StockTitan50 · neutralgeneral
Biodesix to Report Third Quarter 2026 Financial Results on November 5, 2026
GlobeNewswire50 · neutralgeneral
Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers
GlobeNewswire63 · neutralproduct/pr
Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers
Business Insider63 · neutralproduct/pr
Biodesix price target raised to $40 from $30 at TD Cowen
The Fly64 · neutralanalyst
Biodesix to Present New Real-World Evidence Supporting Integration of Nodify Lung® Testing into Routine Lung Nodule Care at CHEST 2026
GlobeNewswire58 · neutralproduct/pr
Biodesix advances two programs for Molecular Residual Disease monitoring
The Fly63 · neutralproduct/pr
Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring
GlobeNewswire67 · bullishproduct/pr
Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring
Business Insider67 · bullishproduct/pr
10 small-cap healthcare stocks with the strongest momentum grades
Seeking Alpha57 · neutralgeneral
Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
GlobeNewswire50 · neutralgeneral
Biodesix: Growing Fast While Trading Below Many Diagnostics Peers
Seeking Alpha67 · bullishgeneral
What Makes Biodesix, Inc. (BDSX) a Strong Momentum Stock: Buy Now?
Quartz57 · neutralanalyst
Biodesix to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Biodesix to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?
Quartz65 · bullishanalyst
Biodesix (BDSX) Q2 2026 Earnings Call Transcript
Yahoo Finance73 · bullishearnings
Biodesix (BDSX) Q2 2026 Earnings Call Transcript
The Motley Fool73 · bullishearnings
Biodesix Sees Nodify Growth, Reaffirms Revenue Outlook at Canaccord Conference
Yahoo Top63 · neutralproduct/pr
Biodesix Price Target Raised To 35 From 27 At Canaccord
The Fly63 · neutralanalyst
Canaccord raises Biodesix stock price target on strong test volume
Investing.com Analyst Ratings63 · neutralanalyst
Biodesix Price Target Raised To 27 From 26 At H C Wainwright
The Fly61 · neutralanalyst
Biodesix, Inc. (BDSX) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Biodesix Q2 Earnings Call Highlights
Yahoo Top67 · bullishearnings
Biodesix GAAP EPS of -$0.71 beats by $0.19, revenue of $26.9M beats by $0.87M
Seeking Alpha63 · neutralearnings